$ News

Pliant Therapeutics: An Activist On Deck

Allakos And 2 Other Promising Penny Stocks To Watch

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share

Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results

Allakos cuts 75% of workforce after chronic hives trial failure

Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring

Discover US Penny Stocks To Watch In January 2025

3 US Penny Stocks Under $200M Market Cap To Watch

All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy

Allakos Runs Up Into A Near-Term Catalyst

Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

3 US Penny Stocks With Market Caps Larger Than $50M

Warning: ALLK is at high risk of performing badly

12 Health Care Stocks Moving In Tuesday's After-Market Session

Jasper gains 11% on data for briquilimab in urticaria

Analysts Conflicted on These Healthcare Names: Allakos (ALLK), Edwards Lifesciences (EW) and NewAmsterdam Pharma Company (NAMS)

Allakos perks up after early-stage data for lead asset

TD Cowen Sticks to Their Hold Rating for Allakos (ALLK)